Biotechnology Innovation Organization (BIO) on Monday announced the resignation of its CEO, molecular immunologist Dr. Michelle McMurry-Heath, after confirming over the weekend that she was on a leave of absence. BIO is the trade association and top lobbying group for the biotech industry, with a membership of over 1,000 companies of all sizes including drug manufacturers, some of which are also members of the brand name manufacturer trade group PhRMA.
The Wall Street Journal was first to report on McMurry-Heath’s leave, saying it took place “amid dissent within the organization about its direction and concern about its results,” according to anonymous sources. McMurry-Heath formally stepped down a day later, and has not commented publicly on her resignation.
Biotechnology Innovation Organization (BIO) on Monday announced the resignation of its CEO, molecular immunologist Dr. Michelle McMurry-Heath, after confirming over the weekend that she was on a leave of absence.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
